NEW YORK (GenomeWeb News) — Roche said today that revenue from its Molecular Diagnostics division declined during the first six months of the year, though overall Diagnostics revenue increased.
 
Also, Applied Science receipts increased on strong sales of its LightCycler 480 and Genome Sequencer 20 and GS FLX systems.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.